Insider Buy/Sell Details for the Biotechnology Industry — August 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1056)
Aurinia Pharmaceuticals Inc. (AUPH)
Robertson Stephen P. — Chief Legal Officer
Shares
20,975
Price
$16.97
Total Value
$355.95K
Shares Held After
600,787
% of Holdings
3.4%
ARDELYX, INC. (ARDX)
Kelliher Mike — Chief Business Officer
Shares
2,002
Price
$3.86
Total Value
$7.72K
Shares Held After
349,660
% of Holdings
0.6%
ARDELYX, INC. (ARDX)
Kelliher Mike — Chief Business Officer
Shares
2,652
Price
$3.86
Total Value
$10.23K
Shares Held After
351,662
% of Holdings
0.7%
ARDELYX, INC. (ARDX)
Kelliher Mike — Chief Business Officer
Shares
3,104
Price
$3.86
Total Value
$11.97K
Shares Held After
354,314
% of Holdings
0.9%
ARDELYX, INC. (ARDX)
Brady James Parker — Chief Human Resources Officer
Shares
13,160
Price
$3.86
Total Value
$50.76K
Shares Held After
245,930
% of Holdings
5.1%
ARDELYX, INC. (ARDX)
Brady James Parker — Chief Human Resources Officer
Shares
1,976
Price
$3.86
Total Value
$7.62K
Shares Held After
259,090
% of Holdings
0.8%
ARDELYX, INC. (ARDX)
Williams Laura A — Chief Patient Officer
Shares
1,734
Price
$3.86
Total Value
$6.69K
Shares Held After
367,456
% of Holdings
0.5%
ARDELYX, INC. (ARDX)
Williams Laura A — Chief Patient Officer
Shares
2,430
Price
$3.86
Total Value
$9.37K
Shares Held After
369,190
% of Holdings
0.7%
ARDELYX, INC. (ARDX)
Williams Laura A — Chief Patient Officer
Shares
3,089
Price
$3.86
Total Value
$11.91K
Shares Held After
371,620
% of Holdings
0.8%
ARDELYX, INC. (ARDX)
Williams Laura A — Chief Patient Officer
Shares
3,486
Price
$3.86
Total Value
$13.45K
Shares Held After
374,709
% of Holdings
0.9%
ARDELYX, INC. (ARDX)
Hohenleitner Susan — Chief Financial Officer
Shares
1,558
Price
$3.86
Total Value
$6.01K
Shares Held After
227,520
% of Holdings
0.7%
ARDELYX, INC. (ARDX)
Foster Eric Duane — Chief Commercial Officer
Shares
2,575
Price
$3.86
Total Value
$9.93K
Shares Held After
409,410
% of Holdings
0.6%
ARDELYX, INC. (ARDX)
Foster Eric Duane — Chief Commercial Officer
Shares
3,389
Price
$3.86
Total Value
$13.07K
Shares Held After
411,985
% of Holdings
0.8%
ARDELYX, INC. (ARDX)
Foster Eric Duane — Chief Commercial Officer
Shares
2,598
Price
$3.86
Total Value
$10.02K
Shares Held After
415,374
% of Holdings
0.6%
ARDELYX, INC. (ARDX)
Bishop John E — Chief Technical and Quality Officer
Shares
2,469
Price
$3.86
Total Value
$9.52K
Shares Held After
317,095
% of Holdings
0.8%
ARDELYX, INC. (ARDX)
Bishop John E — Chief Technical and Quality Officer
Shares
17,281
Price
$3.86
Total Value
$66.65K
Shares Held After
319,564
% of Holdings
5.1%
ARDELYX, INC. (ARDX)
Reilly Joseph James — Senior Vice President and Chief Accounting Officer
Shares
1,110
Price
$3.86
Total Value
$4.28K
Shares Held After
145,854
% of Holdings
0.8%
ARDELYX, INC. (ARDX)
Reilly Joseph James — Senior Vice President and Chief Accounting Officer
Shares
2,872
Price
$3.86
Total Value
$11.08K
Shares Held After
146,964
% of Holdings
1.9%
ARDELYX, INC. (ARDX)
RAAB MICHAEL — Director
Shares
19,178
Price
$3.86
Total Value
$73.97K
Shares Held After
1,619,792
% of Holdings
1.2%
ARDELYX, INC. (ARDX)
RAAB MICHAEL — Director
Shares
8,411
Price
$3.86
Total Value
$32.44K
Shares Held After
1,638,970
% of Holdings
0.5%
ARDELYX, INC. (ARDX)
RAAB MICHAEL — Director
Shares
15,976
Price
$3.86
Total Value
$61.62K
Shares Held After
1,647,381
% of Holdings
1.0%
ARDELYX, INC. (ARDX)
RAAB MICHAEL — Director
Shares
15,009
Price
$3.86
Total Value
$57.89K
Shares Held After
1,663,357
% of Holdings
0.9%
OMEROS CORP (OMER)
Borges David J. — VP, Finance&CAO
Shares
10,000
Price
$18.95
Total Value
$189.50K
Shares Held After
0
% of Holdings
100.0%
Mineralys Therapeutics, Inc. (MLYS)
Warren Eric — Chief Commercial Officer
Shares
7,437
Price
$25.98
Total Value
$193.19K
Shares Held After
38,400
% of Holdings
16.2%
PRECIGEN, INC. (PGEN)
AGEE NANCY H — Director
Shares
3,411
Price
$7.23
Total Value
$24.66K
Shares Held After
309,187
% of Holdings
1.1%
PRECIGEN, INC. (PGEN)
Shah Rutul R — Chief Operating Officer
Shares
34,658
Price
$7.50
Total Value
$259.94K
Shares Held After
465,012
% of Holdings
6.9%
Allogene Therapeutics, Inc. (ALLO)
Douglas Earl Martin — SVP, General Counsel
Shares
29,697
Price
$2.12
Total Value
$62.96K
Shares Held After
488,267
% of Holdings
5.7%
Liquidia Corp (LQDA)
Adair Jason — Chief Business Officer
Shares
41,832
Price
$69.09
Total Value
$2.89M
Shares Held After
174,606
% of Holdings
19.3%
Liquidia Corp (LQDA)
Adair Jason — Chief Business Officer
Shares
31,799
Price
$69.09
Total Value
$2.20M
Shares Held After
216,438
% of Holdings
12.8%
Lyell Immunopharma, Inc. (LYEL)
Lee Gary K. — Chief Scientific Officer
Shares
1,457
Price
$15.54
Total Value
$22.64K
Shares Held After
16,220
% of Holdings
8.2%
Revolution Medicines, Inc. (RVMD)
GOLDSMITH MARK A — Director
Shares
126
Price
$212.06
Total Value
$26.72K
Shares Held After
61,424
% of Holdings
0.2%
Revolution Medicines, Inc. (RVMD)
GOLDSMITH MARK A — Director
Shares
229
Price
$211.46
Total Value
$48.43K
Shares Held After
61,550
% of Holdings
0.4%
Revolution Medicines, Inc. (RVMD)
GOLDSMITH MARK A — Director
Shares
126
Price
$210.40
Total Value
$26.51K
Shares Held After
61,779
% of Holdings
0.2%
Revolution Medicines, Inc. (RVMD)
GOLDSMITH MARK A — Director
Shares
1,405
Price
$209.27
Total Value
$294.02K
Shares Held After
61,905
% of Holdings
2.2%
Revolution Medicines, Inc. (RVMD)
GOLDSMITH MARK A — Director
Shares
937
Price
$208.36
Total Value
$195.23K
Shares Held After
63,310
% of Holdings
1.5%
Revolution Medicines, Inc. (RVMD)
GOLDSMITH MARK A — Director
Shares
177
Price
$207.25
Total Value
$36.68K
Shares Held After
64,247
% of Holdings
0.3%
Revolution Medicines, Inc. (RVMD)
GOLDSMITH MARK A — Director
Shares
127
Price
$212.06
Total Value
$26.93K
Shares Held After
61,424
% of Holdings
0.2%
Revolution Medicines, Inc. (RVMD)
GOLDSMITH MARK A — Director
Shares
245
Price
$211.47
Total Value
$51.81K
Shares Held After
61,551
% of Holdings
0.4%
Revolution Medicines, Inc. (RVMD)
GOLDSMITH MARK A — Director
Shares
136
Price
$210.40
Total Value
$28.61K
Shares Held After
61,796
% of Holdings
0.2%
Revolution Medicines, Inc. (RVMD)
GOLDSMITH MARK A — Director
Shares
1,351
Price
$209.28
Total Value
$282.74K
Shares Held After
61,932
% of Holdings
2.1%
Revolution Medicines, Inc. (RVMD)
GOLDSMITH MARK A — Director
Shares
951
Price
$208.36
Total Value
$198.15K
Shares Held After
63,283
% of Holdings
1.5%
Revolution Medicines, Inc. (RVMD)
GOLDSMITH MARK A — Director
Shares
190
Price
$207.25
Total Value
$39.38K
Shares Held After
64,234
% of Holdings
0.3%
Revolution Medicines, Inc. (RVMD)
GOLDSMITH MARK A — Director
Shares
3,621
Price
$212.08
Total Value
$767.93K
Shares Held After
267,330
% of Holdings
1.3%
Revolution Medicines, Inc. (RVMD)
GOLDSMITH MARK A — Director
Shares
6,583
Price
$211.33
Total Value
$1.39M
Shares Held After
270,951
% of Holdings
2.4%
Revolution Medicines, Inc. (RVMD)
GOLDSMITH MARK A — Director
Shares
3,813
Price
$210.25
Total Value
$801.67K
Shares Held After
277,534
% of Holdings
1.4%
Revolution Medicines, Inc. (RVMD)
GOLDSMITH MARK A — Director
Shares
35,938
Price
$209.26
Total Value
$7.52M
Shares Held After
281,347
% of Holdings
11.3%
Revolution Medicines, Inc. (RVMD)
GOLDSMITH MARK A — Director
Shares
24,917
Price
$208.37
Total Value
$5.19M
Shares Held After
317,285
% of Holdings
7.3%
Revolution Medicines, Inc. (RVMD)
GOLDSMITH MARK A — Director
Shares
5,128
Price
$207.23
Total Value
$1.06M
Shares Held After
342,202
% of Holdings
1.5%
Lyell Immunopharma, Inc. (LYEL)
Hill Stephen J. — Chief Operating Officer
Shares
989
Price
$15.54
Total Value
$15.37K
Shares Held After
16,816
% of Holdings
5.6%
Lyell Immunopharma, Inc. (LYEL)
Seely Lynn — Director
Shares
9,589
Price
$15.54
Total Value
$149.01K
Shares Held After
63,899
% of Holdings
13.0%
Showing 201–250 of 1056 transactions (page 5 of 22)